|
|
In general terms, Dr. Saygin’s research focuses on improving the quality of life and longevity of individuals with inflammatory myopathies. Dr. Saygin has validated numerous myositis outcome measures including objective tools and patient-reported outcome measures in order to optimize the assessment of muscle strength and other disease related symptoms such as fatigue, pain, and physical function in both clinical practice and therapeutic trials. She has a particular interest in clinical trials, relationship between cancer and myositis, myositis associated interstitial lung disease, and immune checkpoint inhibitor induced myositis.
|
